|
|
||||||||||
|
J Am Coll Cardiol, 1997; 29:693-701 © 1997 by the American College of Cardiology Foundation |
Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan. miura@sapmed.ac.jp
OBJECTIVES: This study examined the effect of a new specific Na(+)-H+ exchange inhibitor, Hoe 642, on infarct size and the protective role of protein kinase C (PKC) by this agent. In addition, we assessed the possible alteration of Hoe 642-induced cardioprotection by commonly used animal anesthetic drugs. BACKGROUND: Earlier studies on the contribution of Na(+)-H+ exchange to ischemic injury were complicated by nonspecific actions of the Na(+)-H+ exchange inhibitors, and the role of this exchanger in myocardial infarction in vivo remains unclear. The difference in anesthetic agents used in experiments could have resulted in discrepant findings regarding cardioprotection of some interventions, such as preconditioning and adenosine triphosphate-sensitive potassium channel openers. METHODS: Infarction was induced by 30 min of coronary occlusion and 3 h of reperfusion in the rabbit heart. In the first series of experiments, rabbits were anesthetized with pentobarbital or ketamine/xylazine. Hoe 642 was injected intravenously 10 min before ischemia or 5 min before reperfusion. In the second series of experiments, rabbits received 25 mg/kg body weight of polymyxin B (polyB), Hoe 642 plus polyB, preconditioning with 5 min of ischemia and 5 min of reperfusion plus polyB or preconditioning alone before 30 min of ischemia. RESULTS: In pentobarbital-anesthetized rabbits, 0.3 mg/kg and 0.6 mg/kg of Hoe 642 given before ischemia limited infarct size (as percent area at risk [%IS/AR]) to 42.7 +/- 4.4% (SEM) and 26.2 +/- 5.4%, respectively, from the control value of 55.1 +/- 3.5%. However, injection of Hoe 642 before reperfusion did not change infarct size (%IS/AR 49.6 +/- 4.9%, p = 0.387; power 0.81 for detecting 50% reduction). Infarct size limitation by the preischemic treatment with Hoe 642 was similarly observed in the rabbits anesthetized with ketamine/xylazine. In the polyB-treated rabbits, 0.6 mg/kg of Hoe 642 significantly limited infarct size (%IS/AR was 28.3 +/- 3.8% with Hoe 642 and 50.1 +/- 7.5% without Hoe 642), although preconditioning was blocked by the same dose of polyB (%IS/AR was 39.3 +/- 6.1% with polyB and 11.3 +/- 2.4% without polyB). CONCLUSIONS: Hoe 642 enhanced myocardial tolerance against infarction, and this enhanced tolerance was not influenced by anesthetic agents commonly used for infarct size studies. Infarct size limitation by Hoe 642 was not inhibited by polyB, suggesting that cardioprotection by Na(+)-H+ exchange inhibition is not PKC mediated and thus may be unrelated to preconditioning.
This article has been cited by other articles:
![]() |
M. Tanno and T. Miura Protecting ischemic hearts by modulation of SR calcium handling Cardiovasc Res, August 1, 2007; 75(3): 453 - 454. [Full Text] [PDF] |
||||
![]() |
N. Maekawa, J.-i. Abe, T. Shishido, S. Itoh, B. Ding, V. K. Sharma, S.-S. Sheu, B. C. Blaxall, and B. C. Berk Inhibiting p90 Ribosomal S6 Kinase Prevents Na+-H+ Exchanger-Mediated Cardiac Ischemia-Reperfusion Injury Circulation, May 30, 2006; 113(21): 2516 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Merrill, T. H. Rork, N. M. Spiler, and R. Golfetti Acetaminophen and myocardial infarction in dogs Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1913 - H1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ten Hove and C. J.A Van Echteld Limited effects of post-ischemic NHE blockade on [Na+]i and pHi in rat hearts explain its lack of cardioprotection Cardiovasc Res, February 15, 2004; 61(3): 522 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Klass, U. M. Fischer, E. Perez, J. Easo, M. Bosse, J. H. Fischer, P. Tossios, and U. Mehlhorn Effect of the Na+/H+ exchange inhibitor eniporide on cardiac performance and myocardial high energy phosphates in pigs subjected to cardioplegic arrest Ann. Thorac. Surg., February 1, 2004; 77(2): 658 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miura, Y. Ohnuma, A. Kuno, M. Tanno, Y. Ichikawa, Y. Nakamura, T. Yano, T. Miki, J. Sakamoto, and K. Shimamoto Protective role of gap junctions in preconditioning against myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H214 - H221. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Corvera, Z.-Q. Zhao, L. S. Schmarkey, S. L. Katzmark, J. M. Budde, C. D. Morris, T. Ehring, R. A. Guyton, and J. Vinten-Johansen Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury Ann. Thorac. Surg., November 1, 2003; 76(5): 1614 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Rabkin, S. E. Cabreriza, J. C. LaCorte, A. D. Weinberg, L. Coku, R. Walsh, R. Mosca, and H. M. Spotnitz Sodium-hydrogen exchange inhibition preserves ventricular function after ventricular fibrillation in the intact swine heart J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1499 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reffelmann and R. A. Kloner Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1134 - H1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Haist, C. N. Hirst, and M. Karmazyn Effective protection by NHE-1 inhibition in ischemic and reperfused heart under preconditioning blockade Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H798 - H803. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Mentzer Jr., M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2003; 2(2003): 413 - 438. [Full Text] |
||||
![]() |
A. Babsky, S. Hekmatyar, S. Wehrli, N. Doliba, M. Osbakken, and N. Bansal Influence of Ischemic Preconditioning on Intracellular Sodium, pH, and Cellular Energy Status in Isolated Perfused Heart Experimental Biology and Medicine, July 1, 2002; 227(7): 520 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-D. Wang, J. Pernow, P.-O. Sjoquist, and L. Ryden Pharmacological possibilities for protection against myocardial reperfusion injury Cardiovasc Res, July 1, 2002; 55(1): 25 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Goldberg, S. B. Digerness, J. L. Skinner, C. R. Killingsworth, C. R. Katholi, and W. L. Holman Ischemic preconditioning and Na+/H+ exchange inhibition improve reperfusion ion homeostasis Ann. Thorac. Surg., February 1, 2002; 73(2): 569 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Toyoda, S. Khan, W. Chen, R. A. Parker, S. Levitsky, and J. D. McCully Effects of NHE-1 inhibition on cardioprotection and impact on protection by K/Mg cardioplegia Ann. Thorac. Surg., September 1, 2001; 72(3): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran, G. Gross, M. Karmazyn, H. Klein, E. Murphy, and K. Ytrehus Na+/H+ exchange in ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 162 - 163. [Full Text] [PDF] |
||||
![]() |
T. Miura, Y. Liu, M. Goto, A. Tsuchida, T. Miki, A. Nakano, Y. Nishino, Y. Ohnuma, and K. Shimamoto Mitochondrial ATP-sensitive K+ channels play a role in cardioprotection by Na+-H+ exchange inhibition against ischemia/reperfusion injury J. Am. Coll. Cardiol., March 1, 2001; 37(3): 957 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Portman, A. L. Panos, Y. Xiao, D. L. Anderson, and X.-H. Ning HOE-642 (cariporide) alters pHi and diastolic function after ischemia during reperfusion in pig hearts in situ Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H830 - H834. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hale and R. A. Kloner Effect of combined KATP channel activation and Na+/H+ exchange inhibition on infarct size in rabbits Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2673 - H2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Klein, S. Pich, R. M. Bohle, S. Lindert-Heimberg, and K. Nebendahl Na+/H+ Exchange Inhibitor Cariporide Attenuates Cell Injury Predominantly During Ischemia and Not at Onset of Reperfusion in Porcine Hearts With Low Residual Blood Flow Circulation, October 17, 2000; 102(16): 1977 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Rupprecht, J. v. Dahl, W. Terres, K. M. Seyfarth, G. Richardt, H.-P. Schulthei{beta}, M. Buerke, F. H. Sheehan, and H. Drexler Cardioprotective Effects of the Na+/H+ Exchange Inhibitor Cariporide in Patients With Acute Anterior Myocardial Infarction Undergoing Direct PTCA Circulation, June 27, 2000; 101(25): 2902 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miura, Y. Liu, H. Kita, T. Ogawa, and K. Shimamoto Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation J. Am. Coll. Cardiol., January 1, 2000; 35(1): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran Protection of the Myocardium During Ischemia and Reperfusion : Na+/H+ Exchange Inhibition Versus Ischemic Preconditioning Circulation, December 21, 1999; 100(25): 2469 - 2472. [Full Text] [PDF] |
||||
![]() |
R. J. Gumina, E. Buerger, C. Eickmeier, J. Moore, J. Daemmgen, and G. J. Gross Inhibition of the Na+/H+ Exchanger Confers Greater Cardioprotection Against 90 Minutes of Myocardial Ischemia Than Ischemic Preconditioning in Dogs Circulation, December 21, 1999; 100(25): 2519 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takaoka, I. Nakae, K. Mitsunami, T. Yabe, S. Morikawa, T. Inubushi, and M. Kinoshita Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning" J. Am. Coll. Cardiol., February 1, 1999; 33(2): 556 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gumina, T. Mizumura, N. Beier, P. Schelling, J. J. Schultz, and G. J. Gross A New Sodium/Hydrogen Exchange Inhibitor, EMD 85131, Limits Infarct Size in Dogs When Administered Before or After Coronary Artery Occlusion J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 175 - 183. [Abstract] [Full Text] |
||||
![]() |
O. Frohlich and M. Karmazyn The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease Cardiovasc Res, November 1, 1997; 36(2): 138 - 148. [Full Text] [PDF] |
||||
![]() |
K. Imahashi, T. Nishimura, J. Yoshioka, and H. Kusuoka Role of Intracellular Na+ Kinetics in Preconditioned Rat Heart Circ. Res., June 8, 2001; 88(11): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |